FDA Drug Safety Oversight Board Should Have More Independent Outside Advisors, Cmte. Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Board Executive Director Susan Cummins maintains that as a "management tool," the DSOB must run in a different way from a public advisory committee.